Form D · Biotechnology
Xhale Innovations, Inc.
Gainesville, FL · CIK 0001476510
Offering snapshot reported Nov 18, 2009 · SEC filing
- Reported sold
- Yet to sell Offering amount: $6.5M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 18, 2009 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Nov 13, 2009 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- Not reported
Source: Form D, filed Nov 18, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard R Allen | Director, Executive, Promoter |
| Kim Barkman | Executive |
| Donn M Dennis | Executive |
| David Dizney | Director |
| Mark S Gold | Director |
| Steven T Gold | Executive |
| John Harper | Director |
| S. Tucker Johnson | Director |
| Richard J Melker | Executive |
| Stephanie Warrington | Executive |
| Hank Wohltjen | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3630 Sw 47 Th Ave., Suite 100
Gainesville, FL, 32608
Gainesville, FL, 32608